Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.027 | 0.7 |
mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |